Compare NNOX & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNOX | GGZ |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 129.8M |
| IPO Year | 2019 | 2013 |
| Metric | NNOX | GGZ |
|---|---|---|
| Price | $2.70 | $15.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 879.4K | 6.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.19 | N/A |
| Revenue Next Year | $137.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $10.50 |
| 52 Week High | $6.22 | $16.80 |
| Indicator | NNOX | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 34.20 |
| Support Level | $2.11 | $15.47 |
| Resistance Level | $3.13 | $16.75 |
| Average True Range (ATR) | 0.15 | 0.27 |
| MACD | 0.06 | -0.13 |
| Stochastic Oscillator | 90.94 | 0.83 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.